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Extracapsular ligament injuries of the knee and ankle are common in sports activities. 
For example, isolated medial collateral ligament (MCL) injuries of the knee joint have been 
found to heal with conservative treatment with bracing and activity restriction for a few 
months required for sufficient healing of the ligament.1 Yet, the mechanical properties, 
collagen types and histological appearance are not restored to pre-injury levels even after 1 
to 2 years.2,3 Clinically, severe isolated MCL injuries take several months for return 
pre-injury activity level, and they may require MCL surgery because of residual valgus 
laxity. Controversy remains regarding the best treatment for the MCL in combined 
ligamentous injuries.1 Thus, enhancement of ligament healing would increase the stability 
of the joint and allow patients to return to athletic activities earlier and with greater safety. 
    Several different approaches, including growth factor treatment, hyaluronan treatment, 
hyperbaric oxygen treatment, gene transfer, cell therapy, mechanical stimulation, and the 
use of scaffolds have been studied in an attempt to accelerate and improve the healing of 
ligaments.4,5,6 Among growth factors, hepatocyte growth factor (HGF) was originally 
identified and cloned as a growth-promoting factor for mature hepatocytes.7,8 The c-Met 
membrane-spanning tyrosine kinase is functional receptor for HGF. The c-Met receptor is 
expressed in a wide variety of cells and HGF-Met coupling exhibits biological activities, 
such as promotion of cell proliferation and migration, prevention of cell death, and 
induction of morphogenesis. Based on these biological activities, HGF plays roles in tissue 
repair and protection. Administration of HGF or expression of the HGF gene promotes 
tissue regeneration or improves pathology in various disease models in different tissues. In 
the field of orthopedic surgery, local expression of the HGF gene promotes healing of bone 
fractures.9 In addition, recombinant HGF administration enhances tendon healing in a bone 
tunnel and leads to improved biomechanical fixation in a shorter period of time.10 HGF 
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prevents fibrosis or scar formation in different tissues after injury and facilitates tissue 
regeneration without fibrotic change.11,12,13,14 The advantages of ligament healing without 
excessive fibrosis and scar formation are considerable for the recovery of a functional 
MCL. 
Based on these previous studies, we hypothesized that HGF administration would 
enhance healing of a ligament and lead to better structural properties in a shorter period of 
time. To test this hypothesis, we locally administered recombinant HGF in a MCL healing 
model in rabbits.  
 
Materials and methods  
HGF 
Recombinant human HGF (the 5 amino acid-deleted type) used in this study was 
obtained from Kringle Pharma, Inc. (Osaka, Japan). 
 
The MCL model in rabbits 
A total of 33 mature female Japanese white rabbits weighing between 2.5 and 3.0 kg 
were used. The animal experiments were carried out in strict accordance with the 
regulations of the Institutional Animal Care and Use Committee, Kanazawa University, 
Japan. The rabbits were anesthetized with sodium pentobarbital (Kyorin Pharmaceutical 
Co., Tokyo, Japan). Using aseptic techniques, each rabbit was subjected to surgical 
transection of the midsubstance of the MCL of both hind limbs, with one limb serving as 
the experimental limb and the contralateral limb serving as the control. The MCL in a rabbit 
is an easily identifiable structure on the medial side of the knee. In this study, the MCLs 
were exposed by a longitudinal incision through the overlying fascia, sharply transected 
just distal to the joint line, but not sutured. A small gap was thus formed between the 
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opposing ligament ends without repair or immobilization. For all rabbits, the wound was 
then irrigated and the fascia and skin were closed with 4-0 nylon sutures. These rabbits 
were allowed to move around unrestricted in individual cages and received a standard diet 
and water. During the immediate post-operative period and at post-operative days 1 to 6, 
the rabbits were injected with 100 μL of 100 μg/mL human recombinant HGF solution into 
the right MCL (HGF-treated group), while the left MCL was injected with 100 μL saline 
(control group). We chose this dose and dosing period based on a previous study in a 
tendon-bone healing model.10 HGF was injected into the MCL gap or scar tissue 
percutaneously using a 29 gauge needle. Before the experimental series, a preliminary 
study was carried out in which 100 μL of aqueous methylene blue solution was injected 
using the same procedure. Because the rabbit knee had been sheared, the MCL gap was 
clearly observed. We confirmed that the injected solution stayed at the gap or scar tissue 
with minimal diffusion to surrounding tissues in the reproducible manner. Rabbits were 
sacrificed with an overdose of sodium pentobarbital as follows: 1 week after surgery, n = 3; 
3, 6 and 12 weeks after surgery, n = 8. The femur-MCL-tibia complexes were extracted 
from both hind limbs. At 1 week after surgery, we performed histological evaluations only. 
At later time points, the 8 rabbits were allocated to either histological evaluation (n = 3) or 
biomechanical evaluation (n = 5). For immunohistochemical analysis of c-Met expression, 
one rabbit was sacrificed after 1, 3, 7, 21, 42 and 84 days. 
 
Immunohistochemical analysis 
Tissues were fixed in 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) 
overnight at 4°C and dehydrated through graded alcohols (80% then 100%). They were 
decalcified using a formic acid-sodium citrate solution. Specimens were embedded in 
paraffin (Histprep568, Wako Junyaku, Osaka, Japan), and then they were sectioned 
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coronally with respect to the MCL. The sections were 2 µm thick and subjected to indirect 
immunofluorescence staining. Paraffin sections were treated with anti-Met (B-2) 
monoclonal antibody (SC-8057, Santa Cruz Biotechnology Inc., California, USA; dilution 
1:100) and peroxidase-conjugated goat anti-mouse immunoglobulin (EnVision, DAKO, 
Carpinteria, CA, USA) was used as the secondary antibody. To develop the color, a DAB 




Femur-MCL-tibia complexes were excised immediately after sacrifice of the rabbit 
and the specimens were rapidly fixed in 10% formalin. Conventional paraffin-embedded 
sections were prepared. The specimens were sectioned at 2 µm thickness coronally with 
respect to the MCL and stained with Masson’s trichrome. Cellularity, vascularity, and 
alignment of collagen fibers were qualitatively assessed during histological evaluation. 
 
Biomechanical evaluation 
The hind limbs of each rabbit were disarticulated at the hip, wrapped in saline-soaked 
gauze, immediately packed in plastic bags and stored at -80°C. The night before 
biomechanical testing, the specimens were thawed at 4°C.15 All soft tissue, including 
muscles and fascia, was removed from the femur and tibia except the MCL. Bones were 
transected 4 to 5 cm from the joint line. The specimens were kept moist with 0.9% saline 
solution during testing. Both the HGF-treated and control femur-MCL-tibia complexes 
from each rabbit were mechanically tested using an electromechanical testing machine 
(AUTO GRAPH DCS25T, Shimadzu Co., Kyoto, Japan). Each femur-MCL-tibia complex 
was mounted in a custom jig to ensure that the tensile load could be applied along the 
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longitudinal axis of the ligament. A tensile force was applied at a constant elongation rate of 
10 mm/min.15 The structural properties of the femur-MCL-tibia complex (maximum load at 
failure, stiffness and energy absorbed at failure) were determined from the 
load-displacement curves of the complex by material testing software (TRAPEZIUM2, 




Statistical significance was calculated using a Student’s t-test to compare results 




Careful examination of the ligaments after 1 week revealed that the gaps in the MCLs 
were not completely filled with reparative tissue. However, by 3 weeks, the MCLs had 
clearly healed and showed a continuous neo-ligamentous tissue. In the HGF-treated and 
control groups, the appearances were similar in terms of scar mass and adhesion. The 
healing tissue was yellowish-white and translucent at the injury site. The boundaries of the 
healing MCL mass were difficult to define because they blended into the surrounding tissue. 
There was no evidence of infection, the decrease in range of motion of the knee joint and 
excessive inhabitation of scar formation in both groups. 
 
Immunohistochemical evaluation 
To see the distribution of cells that express c-Met receptor, tissues at the injury sites 
were subjected to immunohistochemistry. In control limbs, clear c-Met expression was not 
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observed (Fig. 1). In contrast, c-Met expression was observed in cells, presumably 
fibroblasts or fibroblastic cells, particularly at opposing ligament ends in the HGF-treated 
limbs 7 days after surgery (Fig. 1).  
 
Histological changes 
One week after surgery, inflammatory cells and fibroblasts infiltrated the edematous 
granulation tissue of the ligament gap in both groups. Neovascularization was observed 
more abundantly in the HGF-treated limbs compared to the reparative tissues in control 
limbs. After 3 weeks, the gaps in the MCLs were filled with granulation tissue, which was 
hypercellular and hypervascular in both groups. Although cells and collagen fibers were 
oriented irregularly in the control limbs, directionally aligned cells and collagen fibers were 
observed in regions in HGF-treated limbs (Fig. 2).  
Six weeks after surgery, cellularity in the reparative tissues in both groups was still 
high, but lower than that observed in specimens obtained at 3 weeks (Fig. 2). The collagen 
fibers in HGF-treated limbs appeared more oriented in the longitudinal direction and tended 
to become parallel to the longitudinal axis of the ligament. Thus, the histological 
maturation in HGF-treated tissues occurred earlier than that in control tissues. After 12 
weeks, the reparative tissues showed decreased cellularity and vascularity compared with 
earlier specimens and displayed improved collagen alignment and cellular organization 
similar to that of a normal MCL (Fig. 2). Although no clear differences between the two 
groups were identified at this point, no histological evidence of a negative effect of HGF 
was observed over the experimental period. 
 
Biomechanical changes 
To see whether the histological improvement in HGF-treated limbs was associated 
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with functional improvement, specimens were subjected to biomechanical evaluation. 
Load-displacement curves were obtained for all specimens. Five rabbits were used in each 
experimental groups, however, the number of specimens available for the biomechanical 
evaluation were as follows: at 3 weeks, 5 specimens in both groups; at 6 weeks, 2 
specimens in the HGF-treated group and 3 control specimens; at 12 weeks, 4 specimens in 
both groups. Because avulsion of the ligament at the tibial insertion site during 
biomechanical test did not reflect the effect of HGF on reparative tissues directly, several 
specimens at 6 weeks and 12 weeks could not be evaluated, Thus, the data at 6 and 12 
weeks after surgery were insufficient for the statistical analysis. Modes of failure included 
midsubstance failure and avulsion from the tibia, with similarity in failure modes noted 
between the two groups. 
Three weeks following surgery, the HGF-treated limbs had a higher maximum load at 
failure, increased stiffness and higher energy absorbed at failure than did the paired control 
limbs. These parameters were significantly greater in the HGF-treated group compared to 




HGF exerts a variety of biological activities in a variety of cells through the activation 
of the c-Met receptor tyrosine kinase. Our immunohistochemical results suggest that c-Met 
expression is inducible in response to administration of HGF to injured ligaments and that 
the percutaneously injected HGF would have a negligible effect on control limbs as a 
systemic effect. 
In the healing process after ligament injuries, various kinds of cells, such as fibroblasts, 
platelets, white blood cells, and bone marrow stromal cells, enter injury sites and play 
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important roles. Bone marrow stromal cells act as progenitor cells in the healing process of 
ligament injuries as well as other tissue or organ injuries.16 Previous studies have shown 
that HGF enhanced recruitment and proliferation of bone marrow-derived progenitor cells 
in the alveolar wall.17 Likewise, it is possible that HGF may recruit mesenchymal stem cells 
and induce proliferation of those cells in the early stages of ligament healing. 
HGF is one of the potent angiogenic growth factors that stimulates endothelial cell 
motility and growth.18 Administration of HGF induced therapeutic angiogenesis in the 
rabbit ischemic hind limb model.19,20 Neovascularization has an important role in ligament 
healing because neutrophils, macrophages, fibroblasts, nutrients, and growth factors gain 
access to the site of injury.21 Therefore, our histological observations of abundant 
neovascularization and fibroblast proliferation indicate enhanced ligament healing in the 
early postoperative phase. Moreover, in the rabbit MCL injury model, the increase in blood 
flow by promoted angiogenesis was associated with its greater healing potential compared 
to the anterior cruciate ligament.22 Likewise, nerve growth factor, which directly or 
indirectly promotes angiogenesis, improved ligament healing in the rat MCL injury 
model.23 These reports support our observations because neovasculization contributed to a 
subsequent improved or accelerated healing response. 
It has been speculated that alignment of collagen is an important component of 
ligament strength. In fact, a previous report proposed that collagen alignment and 
cross-linking of collagen fibers is more critical in determining scar strength than the 
volume of collagen produced.24 We here observed that HGF treatment facilitated alignment 
of collagen fibers and facilitated ligament healing in the early postoperative phase. 
Mechanical loading, which stimulates the healing process and alignment of collagen fibers, 
occurs early in the process when a sufficient number of fibroblasts are present and a matrix 
capable of transmitting some load is produced.25 Therefore, it is important to fill the 
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ligament gap with reparative tissue as early as possible. A previous in vitro study 
demonstrated that HGF stimulated the migration and proliferation of ligament fibroblasts.26 
Thus, local delivery of recombinant HGF may play a role in the recruitment/migration and 
proliferation of ligament fibroblasts during the early stages of healing when reparative 
tissues are subject to mechanical stress. Enhanced biomechanical recovery by HGF seems 
to be supported by histological observations that HGF-treated limbs possess well-aligned 
collagen fibers during the early stages. 
In our study, HGF-treated limbs had significantly improved structural properties and 
more mature histological findings than the paired control limbs at 3 weeks after surgery. At 
6 and 12 weeks after surgery, the differences between the HGF-treated and control groups 
in histological findings had gradually decreased. There are several possible explanations for 
these results. First, we administrated HGF only during the immediate post-operative period 
and on post-operative days 1 to 6. Second, the bioactivities of HGF, such as enhancement 
of migration and proliferation of ligament fibroblasts, promotion of neovascularization and 
recruitment of bone marrow stromal cells, seem to work in the early inflammatory and 
proliferation stages of ligament healing. 
There are some limitations to this study. First, we did not investigate how long the 
administered HGF remained and retained in active at the ligament gap. Second, present 
study did not include further analysis to determine change in gene expression for type I and 
type III collagen. Third, the evaluation was limited to a 12 weeks period. The animal model 
may not represent the clinical situation on many aspects such as injury type, post injury 
rehabilitation. However, the positive results in this study suggest that the approach of using 
HGF to accelerate early ligament healing is promising. As to clinical relevance, the 
evaluation of the optimal dosage and its duration will be an important issue for future 
studies. It is an advantage that administration of HGF by percutaneous injection is simple 
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and does not require a surgery or a technically complex procedure, because extracapsular 
ligament injuries are typically treated with conservative therapy. For future treatment, if 
combined with appropriate post injury rehabilitation protocols, the clinical outcomes of the 
patients could be better. 
In this study, we demonstrated that percutaneous injection of human recombinant HGF 
into an injured MCL in rabbits effectively promoted early ligament healing and had no side 
effects in the areas surrounding the injection. This is the first in vivo study to address the 
therapeutic effects of human recombinant HGF on ligament healing. The present data 
indicate the potential of HGF therapy for the treatment of ligament injuries. Local 
administration of recombinant HGF soon after ligament damage should shorten the time 
required for healing. Subsequent rapid recovery of biomechanical properties may accelerate 




In a rabbit model, local administration of recombinant HGF promotes early ligament 
healing. Local administration of HGF may represent a new therapeutic approach to 
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Figure 1. Expression and distribution of c-Met/Hepatocyte growth factor (HGF) receptor in 
the healing site. They were analyzed by immunohistochemistry in HGF-treated and control 
limbs at 7 days after surgery. The boxed areas are shown at higher magnification in lower 
panels. 
 
Figure 2. Changes in histological findings of the healing site by hepatocyte growth 
factor-treatment (Masson's trichrome staining). The double-headed arrows indicate the 
longitudinal axis of the ligament. The boxed area at higher magnification is shown in the 
right to show neovascularity. 
 
Figure 3. Changes of the maximum load at failure, stiffness and the energy absorbed at 
failure of the femur-medial collateral ligament-tibia complex by hepatocyte growth 
factor-treatment at 3 weeks after surgery. Bars represent mean ± SEM (* p < 0.05). 
 



